SCHEMBL16470484

SCHEMBL16470484

CN(C)c1cccc(N(C(=O)O)N2CCCC2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
KDM4E B2RXH2 3/20 0.41
ALDH1A1 P00352 2/20 0.41
TSHR P16473 1/20 0.41
RAB9A P51151 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
NPC1 O15118 1/20 0.40
GFER P55789 1/20 0.40
HSD17B10 Q99714 1/20 0.40
MAPT P10636 3/20 0.39
KDM2B Q8NHM5 1/20 0.38
AVPR2 P30518 1/20 0.38
FFAR4 Q5NUL3 1/20 0.38
FFAR1 O14842 1/20 0.38
TRPV1 Q8NER1 2/20 0.38
BCHE P06276 1/20 0.38
ACHE P22303 1/20 0.38
TERT O14746 1/20 0.37
ABL1 P00519 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29693696 0.86 KDM4E (0.40) KMT2AKDM4EALDH1A1TSHRRAB9A
SCHEMBL8544469 0.81 ALDH1A1 (0.45) L3MBTL1KDM4EALDH1A1TSHRRAB9A
SCHEMBL4142245 0.80 ALDH1A1 (0.47) KMT2AKDM4EALDH1A1TSHRSMN1; SMN2
SCHEMBL1162365 0.77 L3MBTL1 (0.40) KMT2AL3MBTL1KDM4EALDH1A1TSHR
SCHEMBL1285362 0.72 ALDH1A1 (0.35) KMT2AKDM4EALDH1A1SMN1; SMN2LMNA
SCHEMBL18428973 0.70 ALDH1A1 (0.45) KMT2AALDH1A1SMN1; SMN2MAPTHTT
SCHEMBL27627705 0.69 HPGD (0.39) KMT2AKDM4EALDH1A1TSHRSMN1; SMN2
SCHEMBL4391221 0.69 ALDH1A1 (0.67) KMT2AL3MBTL1KDM4EALDH1A1TSHR
SCHEMBL28026626 0.68 ALDH1A1 (0.42) KMT2AL3MBTL1KDM4EALDH1A1TSHR
SCHEMBL7486913 0.68 CHRNB2 (0.33) L3MBTL1ALDH1A1TSHRRAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10017481-B2 Conformationally constrained, fully synthetic macrocyclic compounds POLYPHOR AG (CH) 2018-07-10 US disclosed
US-20150051183-A1 CONFORMATIONALLY CONSTRAINED, FULLY SYNTHETIC MACROCYCLIC COMPOUNDS POLYPHOR AG (CH) 2015-02-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10017481-B2 Conformationally constrained, fully synthetic macrocyclic compounds CTSE, CTSB, CTSS KMT2A 4608/4885L3MBTL1 1546/4885KDM4E 2839/4885
US-20150051183-A1 CONFORMATIONALLY CONSTRAINED, FULLY SYNTHETIC MACROCYCLIC COMPOUNDS CTSE, CTSB, CTSS KMT2A 4608/4885L3MBTL1 1546/4885KDM4E 2839/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.